Leading the Way in Ethical AI: A Biopharma Transformation
A global biopharmaceutical company identified gaps in its AI governance framework and collaborated with EY to enhance responsible AI practices, ensuring compliance, mitigating risks, and maintaining a human-centric AI approach.